News
More information: Zehui Guo et al, Peptide bridging for cofactor channeling in fusion enzyme lowers cofactor input by two orders of magnitude, Chinese Journal of Catalysis (2025). DOI: 10.1016 ...
Cofactor Genomics Presents Breakthrough Work Combining RNA and AI to bring Precision Medicine to Immunotherapy at RNA Society’s 30th Annual Meeting Cofactor Genomics announced the latest ...
Marvel Games; NetEase Games; @mmmmmmmmiller via X.com According to the Marvel Rivals dev team's announcement video, Ultron's Battle Matrix Protocol autochess mode will launch on Friday ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows recent Medicare coverage of the OncoPrism ...
Jarret Glasscock, founder and CEO, transitions to Chief Technology Officer (CTO), Board Member, and President ST. LOUIS, January 08, 2025--(BUSINESS WIRE)--Cofactor Genomics, Inc., a commercial ...
Red pill or blue pill, anyone? The beloved “Matrix” movie franchise is expanding with an upcoming fifth installment, with the film’s original co-writer and co-director Lana Wachowski leading ...
SAINT LOUIS, Mo.--(BUSINESS WIRE)--Cofactor Genomics, the company bridging the precision medicine gap, today announced successful validation of the OncoPrism immunotherapy predictive diagnostic ...
Twenty-five institutions collaborate with Cofactor to validate OncoPrism for use in head and neck cancer patients. SAINT LOUIS, Mo.–(BUSINESS WIRE)–November 17, 2023– Cofactor Genomics ...
San Francisco, California--(Newsfile Corp. - September 8, 2022) - Cofactor Genomics, a Predictive Immune Modeling company, today presented initial results from the PREDAPT (Predicting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results